Annimalcare sells Identicare, resulting in material value creation for shareholders from non-core asset
28 February 2024
Share this article
Animalcare Group plc, the international animal health business, announces that it has disposed of its majority shareholding in Identicare Ltd (“Identicare”) to BG Bidco 21 Limited, a newly incorporated company owned by funds managed by Bridgepoint Advisors II Limited, for a cash consideration of £24.9m (the “Consideration”) payable upon completion of this sale. This represents a significant crystallisation of value for the Company and its shareholders from a non-core asset and allows the Company to focus on growth in its pharmaceutical-based animal health market.